Insulin resistance in Laron syndrome (primary insulin-like growth factor-I (IGF-I) deficiency) and effect of IGF-I replacement therapy

Journal of Pediatric Endocrinology and Metabolism

Volumn 10, Issue SUPPL. 1, 1997, Pages 105-115

  Laron, Zvi ^a   Avitzur, Yaron ^b   Klinger, Beatrice ^b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b NONE

Author keywords

IGF I deficiency; IGF I treatment; insulin resistance; Laron syndrome

Indexed keywords

CARBOHYDRATE; FK 780; GLUCOSE; GROWTH HORMONE; INSULIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AUTOSOMAL RECESSIVE DISORDER; CARBOHYDRATE METABOLISM; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INFANT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LARON SYNDROME; MALE; ORAL GLUCOSE TOLERANCE TEST; SIGNAL TRANSDUCTION;

EID: 0030972750     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.1997.10.s1.105     Document Type: Conference Paper

References (37)

1. Laron Z. Deficiencies of growth hormone and somatomedins in man. In: Cohen MP, Foa PP, eds. Special Topics in Endocrinology and Metabolism. New York: Allan R. Liss, Inc., 1983; 5: 149-199.
2. Raymond MW, Karl I, Weldon VVW, Pagliara AS. The role of growth hormone and cortisone on glucose and gluconeogenic substrate regulation in fasted hypopituitary children. J Clin Endocrinol Metab 1976; 42: 846-856.
3. Wass JA, Cudworth AG, Bottezzo GF, Woodrow JC, Besser GM. An assessment of glucose intolerance in acromegaly and its response to medical treatment. Clin Endocrinol 1980; 12: 53-59.
4. Laron Z, Blum W, Chatelain P, Ranke M, Rosenfeld R, Savage M, Underwood L. Classification of growth hormone insensitivity syndrome. J Pediatr 1993; 122: 241.
5. Eshet R, Laron Z, Pertzelan A, Dintzman M. Defect of human growth hormone receptors in the liver of two patients with Laron type syndrome. Isr J Med Sci 1984; 20: 8-11.
6. Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z, Wood WI. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 1989; 86: 8083-8087.
7. Brown MR, Meacham LR, Pfäffle RW, Murphy TC, Keret R, Klinger B, Laron Z, Parks JS. The molecular defect in Laron syndrome: Exon deletions. Pediatr Adolesc Endocrinol 1993; 24: 127-131.
8. Amselem S, Sobrier ML, Dastot F, Duquesnoy P, Duriez B, Goossens M. Molecular basis of inherited growth hormone resistance in childhood. Balliere's Clin Endocrinol Metab 1996; 10: 353-369.
9. Laron Z, Klinger B, Erster B, Silbergeld A. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism. Acta Endocrinol (Copenh) 1989; 121: 603-608.
10. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI. Growth hormone receptor and serum binding protein: Purification, cloning and expression. Nature 1987; 330: 537-543.
11. Laron Z, Klinger B, Eshet R, Kaneti H, Karasik A, Silbergeld A. Laron syndrome due to a post-receptor defect: Response to IGF-I treatment. Isr J Med Sci 1993; 29: 757-763.
12. Woods KA, Fraser NC, Postel-Vinay MC, Dusquenoy P, Savage MO, Clark AJL. A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab 1996; 81: 1686-1690.
13. Silbergeld A, Dastot F, Klinger B, Kanety H, Eshet R, Amselem S, Laron Z. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: Extended phenotypic study in a very large pedigree. J Pediatr Endocrinol Metab (in press).
14. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Isr J Med Sci 1966; 2: 152-155.
15. Laron Z. Laron syndrome: from description to therapy. Endocrinologist 1993; 3: 21-28.
16. Laron Z. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient. J Clin Endocrinol Metab 1995; 80: 1526-1531.
17. Laron Z, Parks JS. Lessons from Laron syndrome (LS) 1966-1992: A model of GH and IGF-I action and interaction. Pediatr Adolesc Endocrinol 1993; 24: 1-367.
18. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994; 15: 369-390.
19. Rosenbloom AL, Guevara-Aguirre J. Bienvenidos a mi tierra de coledad: From poetry to molecular biology in Southern Ecuador. J Clin Endocrinol Metab 1994: 79: 695-702.
20. Laron Z, Pertzelan A, Karp M. Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci 1968; 4: 883-894.
21. Laron Z, Klinger B. Body fat in Laron syndrome patients: Effect of insulin-like growth factor I treatment. Horm Res 1993; 40: 16-22.
22. Laron Z, Klinger B, Grunebaum M. Laron type dwarfism. Special Feature - Picture of the Month. Am J Dis Child 1991; 145: 473-474.
23. Laron Z, Karp M. Carbohydrate metabolism in the syndrome of familial dwarfism and high plasma immunoreactive growth hormone (Laron type dwarfism). In: Podolsky S, Viswanathan M, eds. Secondary Diabetes: The Spectrum of the Diabetic Syndrome. New York: Raven Press, 1980; 363-371.
24. Laron Z, Avitzur Y, Klinger B. Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor I treatment Metabolism 1995; 44: 113-118.
25. Laron Z, Aurbach-Klipper Y, Flasterstein B, Litwin A, Dickerman Z, Heding LG. Changes in endogenous insulin secretion during childhood as expressed by plasma and urinary C-peptide. Clin Endocrinol (Oxf) 1988; 29: 625-632.
26. Josefsberg Z, Vilunski E, Hanukuglu A, Bialik O, Brown M, Karp M, Laron Z. Glucose and insulin response to an oral glucose load in normal children and adolescents in Israel. Isr J Med Sci 1976; 12: 189-194.
27. Laron Z, Sarel R, Pertzelan A. Puberty in Laron-type dwarfism. Eur J Pediatr 1980; 134: 79-83.
28. Laron Z, Klinger B, Erster B, Anin S. Effects of insulin like growth factor I in patients with Laron dwarfism. Lancet 1988; 2; 1170-1172.
29. Laron Z, Klinger B, Silbergeld A, Lewin R, Erster B, Gil Ad I. Intravenous administration of rIGF-I lowers serum GHRH and TSH. Acta Endocrinol (Copenh) 1990; 123: 378-382.
30. Laron Z, Anin S, Klipper-Aurbach Y, Klinger B. Effects of insulin-like growth factor on linear growth, head circumference and body fat in patients with Laron type dwarfism. Lancet 1992; 339: 1258-1261.
31. Laron Z, Klinger B. IGF-I treatment of adult patients with Laron syndrome: Preliminary results. Clin Endocrinol (Oxf) 1994; 41: 631-638.
32. Klinger B, Laron Z, Three year IGF-I treatment of children with Laron syndrome. J Pediatr Endocrinol Metab 1995; 8: 149-158.
33. Klinger B, Avitzur Y, Laron Z. Changing pattern with age of glucose tolerance in patients with Laron syndrome. Horm Res 1994; 41: 85 (Abstr 113).
34. Laron Z, Pertzelan A, Karp M, Keret R, Eshet R, Silbergeld A. Laron syndrome - a unique model of IGF-I deficiency. In: Laron Z, Parks JS, eds. Lessons from Laron syndrome (LS) 1966-1992 - A Model of GH and IGF-I Action and Interaction. Pediatr Adolesc Endocrinol 1993; 24: 3-23.
35. Karnieli E, Laron Z, Richer N, Singer P, Wasserman M, Meyerovitch Y, Harel C, Swirsky B. Insulin resistance in GH-deficient adult patients treated with human growth hormone: Evidence for a postbinding defect in vivo. In: Laron Z, Butenandt O, eds. Growth Hormone Replacement Therapy in Adults - Pros and Cons. Tel Aviv-London: Freund Publ. House, 1993; 41-50.
36. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson B-A. Growth hormone-deficient adults are insulin-resistant. Metabolism 1995; 44: 1126-1129.
37. Merimee T, Laron Z. Growth Hormone, IGF-I and Growth. New Views on Old Concepts. Modern Endocrinology and Diabetes Series, Vol. 4. Tel Aviv-London: Freund Publ. House, 1996; 5-10.